Medical Device News Magazine

Daniel Yeager Appointed New Senior V.P. of Market Development Of The Wound Pros

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

December 23, 2020

Daniel Yeager is the new Senior Vice President of Market Development of The Wound Pros, who specializes in the treatment and management of chronic non-healing wounds in long-term care facilities. The physician-owned and managed company is also an accredited supplier of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) and a participating Medicare Part B provider.

Daniel Yeager is a business professional with a vast amount of experience in sales, marketing, training, business development, and strategic planning. He graduated with honors from Capella University, Minnesota, earning a Bachelor’s Degree in Business Administration. With almost ten years of work experience, Daniel has developed a unique skill set that portrays excellence in his work ethic, dedication, and commitment to professional and personal growth. As Senior Vice President of Market Development, he will prioritize the continuous growth and refinement of The Wound Pros market expansion and business strategies.

Despite the COVID-19 pandemic, 2020 has been a remarkable year for The Wound Pros. The company has rapidly grown and expanded its operations into 16 states of the U.S. This year, it introduced RITA, an AI-enabled wound measurement app for assessing patients’ wounds at the bedside or remotely and generating relevant documentation to support wound care teams. In response to the pandemic, it developed a camera-based health and wellness monitoring app for tracking variations in users’ vital signs, including heart rate, respiratory rate, heart rate variability (HRV), oxygen saturation, mental stress, and blood pressure. Routine monitoring of vital signs, particularly oxygen saturation can effectively predict COVID-19 infection to curb the spread.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”